Transition Therapeutics Inc. (TTH.TO) Announces Third Quarter Fiscal 2013 Financial Results
5/8/2013 6:22:46 AM
More...
|
Transition Therapeutics Inc. (TTH.TO) to Hold Conference Call on Third Quarter Fiscal 2013 Financial Results on Tuesday, May 7th, at 4:30 P.M. EST
5/6/2013 10:15:42 AM
More...
|
Transition Therapeutics Inc. (TTH.TO) Study on Type 2 Diabetes Better Than Expected
4/30/2013 9:21:21 AM
More...
|
Transition Therapeutics Inc. (TTH.TO) Announces Second Quarter Fiscal 2013 Financial Results
2/8/2013 7:13:51 AM
More...
|
Transition Therapeutics Inc. (TTH.TO) to Hold Conference Call on Second Quarter Fiscal 2013 Financial Results on Thursday, February 7th, at 4:30 P.M. EST
2/4/2013 10:36:45 AM
More...
|
Transition Therapeutics Inc. (TTH.TO) Announces Enrollment of the First Patient in Phase 2 Study of ELND005 (Scyllo-inositol) for the Treatment of Agitation/Aggression in Patients with Alzheimer's Disease
11/28/2012 8:51:33 AM
More...
|
Transition Therapeutics Inc. (TTH.TO) Announces First Quarter Fiscal 2013 Financial Results
11/9/2012 10:09:17 AM
More...
|
Transition Therapeutics Inc. (TTH.TO) to Hold Conference Call on First Quarter Fiscal 2013 Financial Results on Thursday, November 8th, at 4:30 P.M. EST
11/6/2012 10:12:28 AM
More...
|
Transition Therapeutics Inc. (TTH.TO) Announces Fiscal 2012 Year End Financial Results
9/17/2012 10:06:22 AM
More...
|
Transition Therapeutics Inc. (TTH.TO) to Hold Conference Call on Full Year Fiscal 2012 Financial Results on Thursday, September 13th, at 4:30 P.M. EST
9/12/2012 10:05:13 AM
More...
|
|